{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:35:32Z","timestamp":1793824532416,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chickenpox is a highly contagious disease caused by the varicella zoster virus (VZV), and in infants, adolescents, adults, pregnant women, and the immunocompromised it can be serious. The best way to prevent chickenpox is immunization with the varicella vaccine. Protective levels of antibodies induced by the varicella vaccine decline over time, but there is currently no formal recommendation for testing anti-varicella zoster virus (VZV) IgG levels in immunized healthcare workers (HCWs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aims of this study were to evaluate the seroprevalence of circulating anti-VZV IgG in a sample a sample of students and residents of the medical school of the University of Bari, the long-term immunogenicity of the varicella vaccine, and the effectiveness of a strategy consisting of a third vaccine booster dose. The study population was screened as part of a biological risk assessment conducted between April 2014 and October 2020. A strategy for the management of non-responders was also examined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The 182 students and residents included in the study had a documented history of immunization (two doses of varicella vaccine). The absence of anti-VZV IgG was determined in 34% (62\/182; 95%CI\u2009=\u200927.2\u201341.4%), with serosusceptibility more common among males than females (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). After a third varicella dose, seroconversion was achieved in 100% of this previously seronegative group. No serious adverse events were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>One-third of the study population immunized against VZV lacked a protective antibody titer, but a third dose of vaccine restored protection. Since it is highly unlikely that VZV will be eliminated in the immediate future, the loss of immunity in a substantial portion of the population implies a risk of varicella outbreaks in the coming years. Screening for varicella immunity in routine assessments of the biological risk of medical students and HCWs may help to prevent nosocomial VZV infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06180-x","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T17:02:51Z","timestamp":1621962171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Francesco Paolo","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria Vittoria","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia Annatea","family":"Germinario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"6180_CR1","unstructured":"CDC. About Chickenpox. Available on: https:\/\/www.cdc.gov\/chickenpox\/about\/index.html. Last accessed: 22 November 2020."},{"issue":"RR04","key":"6180_CR2","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, et al. Prevention of Varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56(RR04):1\u201340.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6180_CR3","unstructured":"WHO. Varicella. Vaccine-Preventable Diseases. Surveillance Standards. Available on: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/WHO_SurveillanceVaccinePreventable_22_Varicella_R1.pdf?ua=1. Last accessed: 24 November 2020."},{"key":"6180_CR4","unstructured":"WHO. Immunization, Vaccines and Biologicals. Varicella. Available on: https:\/\/www.who.int\/immunization\/diseases\/varicella\/en\/. Last accessed: 22 November 2020."},{"key":"6180_CR5","unstructured":"CDC. Monitoring the Impact of Varicella Vaccination. Available on: https:\/\/www.cdc.gov\/chickenpox\/surveillance\/monitoring-varicella.html. Last accessed: 20 November 2020."},{"key":"6180_CR6","unstructured":"CDC. Impact of the Varicella Vaccination Program. Available on: https:\/\/www.cdc.gov\/chickenpox\/hcp\/index.html#vaccination-impact. Last accessed: 15 November 2020."},{"key":"6180_CR7","unstructured":"CDC. Varicella Vaccine Recommendations. Available on: https:\/\/www.cdc.gov\/vaccines\/vpd\/varicella\/hcp\/recommendations.html. Last accessed: 24 November 2020."},{"key":"6180_CR8","unstructured":"CDC. About the Varicella Vaccines. Available on: https:\/\/www.cdc.gov\/vaccines\/vpd\/varicella\/hcp\/about-vaccine.html. Last accessed: 28 November 2020."},{"issue":"8","key":"6180_CR9","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1080\/21645515.2019.1704124","volume":"16","author":"P Stefanizzi","year":"2020","unstructured":"Stefanizzi P, De Nitto S, Patano F, Bianchi FP, Ferorelli D, Stella P, et al. Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017. Hum Vaccin Immunother. 2020 Aug 2;16(8):1875\u201383. https:\/\/doi.org\/10.1080\/21645515.2019.1704124.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"6180_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/vaccines7040140","volume":"7","author":"P Stefanizzi","year":"2019","unstructured":"Stefanizzi P, Stella P, Ancona D, Malcangi KN, Bianchi FP, De Nitto S, et al. Adverse events following measles-mumps-rubella-varicella vaccination and the case of seizures: a post marketing active surveillance in Puglia Italian region, 2017-2018. Vaccines (Basel). 2019 Oct 7;7(4):140. https:\/\/doi.org\/10.3390\/vaccines7040140.","journal-title":"Vaccines (Basel)."},{"key":"6180_CR11","unstructured":"Italian Ministry of Health. Decree-Law 07 June 2017, n. 73. Urgent provisions on vaccination prevention. G.U. General Serie, n. 130 of 07 June 2017. Available on: http:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=59548. Last accessed on 25 november 2020."},{"key":"6180_CR12","unstructured":"Italian Ministry of Health. National Plan of Vaccinal Prevention (PNPV) 2017-2019. Available on: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf. Last accessed on 29 November 2020."},{"key":"6180_CR13","first-page":"1","volume":"9","author":"O Balbi","year":"2020","unstructured":"Balbi O, Baldi S, Rizza S, Pietroiusti A, Perrone S, Coppeta L. Seroprevalence survey for varicella among healthcare workers and medical students in Italy. Hum Vaccin Immunother. 2020 Jul;9:1\u20135.","journal-title":"Hum Vaccin Immunother."},{"key":"6180_CR14","first-page":"1","volume":"5","author":"L Coppeta","year":"2020","unstructured":"Coppeta L, D'Alessandro I, Pietroiusti A, Somma G, Balbi O, Iannuzzi I, et al. Seroprevalence for vaccine-preventable diseases among Italian healthcare workers. Hum Vaccin Immunother. 2020 Oct;5:1\u20135.","journal-title":"Hum Vaccin Immunother."},{"issue":"2","key":"6180_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/vaccines8020214","volume":"8","author":"CM Trombetta","year":"2020","unstructured":"Trombetta CM, Montomoli E, Viviani S, Coluccio R, Marchi S. Evaluation of varicella immunity during pregnancy in Apulia region, southern Italy. Vaccines (Basel). 2020 May 10;8(2):214. https:\/\/doi.org\/10.3390\/vaccines8020214.","journal-title":"Vaccines (Basel)"},{"issue":"48","key":"6180_CR16","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1016\/j.vaccine.2014.08.088","volume":"32","author":"S Tafuri","year":"2014","unstructured":"Tafuri S, Gallone MS, Cappelli MG, Gallone MF, Larocca AM, Germinario C. A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy). Vaccine. 2014 Nov 12;32(48):6544\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.088.","journal-title":"Vaccine."},{"issue":"6","key":"6180_CR17","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.vaccine.2009.11.047","volume":"28","author":"S Tafuri","year":"2010","unstructured":"Tafuri S, Martinelli D, De Palma M, Germinario C, Prato R. Report of varicella outbreak in a low vaccination coverage group of otherwise healthy children in Italy: the role of breakthrough and the need of a second dose of vaccine. Vaccine. 2010 Feb 10;28(6):1594\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.047.","journal-title":"Vaccine."},{"key":"6180_CR18","doi-asserted-by":"crossref","unstructured":"Bianchi FP, Gallone MS, Gallone MF, Larocca AMV, Vimercati L, Quarto M, Tafuri S. HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students. J Viral Hepat. 2019;26(1):136\u201344.","DOI":"10.1111\/jvh.13001"},{"key":"6180_CR19","unstructured":"DiaSorin. The Diagnostic Specialist. LIAISON\u00ae VZV IgG. The fully automated solution for antibody detection. Available on: https:\/\/www.diasorin.com\/sites\/default\/files\/allegati_prodotti\/ese_scheda_vzv_rev_02_low.pdf. Last accessed on 01 December 2020."},{"key":"6180_CR20","unstructured":"Cabrillo College. Clinical compliance basics. Health Screening Varicella Available on: https:\/\/www.cabrillo.edu\/services\/health\/clinical-compliance\/clinical-varicella.html. Last accessed 04 November 2020."},{"key":"6180_CR21","doi-asserted-by":"crossref","unstructured":"Bianchi FP, Stefanizzi P, De Nitto S, Larocca AMV, Germinario C, Tafuri S. Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study. J Infect Dis. 2020;221(5):721\u20138.","DOI":"10.1093\/infdis\/jiz508"},{"issue":"554","key":"6180_CR22","doi-asserted-by":"publisher","first-page":"eabd3631","DOI":"10.1126\/scitranslmed.abd3631","volume":"12","author":"GP Morris","year":"2020","unstructured":"Morris GP. Understanding sex-related differences in immune responses. Sci Transl Med. 2020;12(554):eabd3631.","journal-title":"Sci Transl Med"},{"key":"6180_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fimmu.2019.01076","volume":"10","author":"E Ortona","year":"2019","unstructured":"Ortona E, Pierdominici M, Rider V. Editorial: Sex Hormones and Gender Differences in Immune Responses. Front Immunol. 2019;10:1076. https:\/\/doi.org\/10.3389\/fimmu.2019.01076.","journal-title":"Front Immunol"},{"issue":"1","key":"6180_CR24","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1186\/s12889-019-7829-3","volume":"19","author":"FP Bianchi","year":"2019","unstructured":"Bianchi FP, De Nitto S, Stefanizzi P, Larocca AMV, Germinario CA, Tafuri S. Immunity to rubella: an Italian retrospective cohort study. BMC Public Health. 2019;19(1):1490. https:\/\/doi.org\/10.1186\/s12889-019-7829-3.","journal-title":"BMC Public Health"},{"key":"6180_CR25","first-page":"1","volume":"18","author":"FP Bianchi","year":"2020","unstructured":"Bianchi FP, De Nitto S, Stefanizzi P, Larocca AMV, Germinario CA, Tafuri S. Long time persistence of antibodies against mumps in fully MMR immunized young adults: an Italian retrospective cohort study. Hum Vaccin Immunother. 2020 Mar;18:1\u20137.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"6180_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jcv.2013.01.015","volume":"57","author":"A Behrman","year":"2013","unstructured":"Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS. Varicella immunity in vaccinated healthcare workers. J Clin Virol. 2013 Jun;57(2):109\u201314. https:\/\/doi.org\/10.1016\/j.jcv.2013.01.015.","journal-title":"J Clin Virol"},{"key":"6180_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijid.2020.04.082","volume":"96","author":"A Trevisan","year":"2020","unstructured":"Trevisan A, Nicolli A, De Nuzzo D, Lago L, Artuso E, Maso S. Varicella seroepidemiology and immunization in a cohort of future healthcare workers in the pre-vaccination era. Int J Infect Dis. 2020 Jul;96:228\u201332. https:\/\/doi.org\/10.1016\/j.ijid.2020.04.082.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"6180_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.292.6.704","volume":"292","author":"JF Seward","year":"2004","unstructured":"Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA. 2004 Aug 11;292(6):704\u20138. https:\/\/doi.org\/10.1001\/jama.292.6.704.","journal-title":"JAMA."},{"issue":"6","key":"6180_CR29","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1086\/338959","volume":"34","author":"K Ampofo","year":"2002","unstructured":"Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis. 2002 Mar 15;34(6):774\u20139. https:\/\/doi.org\/10.1086\/338959.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"6180_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/14760584.2017.1294069","volume":"16","author":"J Leung","year":"2017","unstructured":"Leung J, Broder KR, Marin M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert Rev Vaccines. 2017 Apr;16(4):391\u2013400. https:\/\/doi.org\/10.1080\/14760584.2017.1294069.","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"6180_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s15010-006-5616-9","volume":"34","author":"B Ludwig","year":"2006","unstructured":"Ludwig B, Kraus FB, Allwinn R, Keim S, Doerr HW, Buxbaum S. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination. Infection. 2006 Aug;34(4):222\u20136. https:\/\/doi.org\/10.1007\/s15010-006-5616-9.","journal-title":"Infection."},{"issue":"7","key":"6180_CR32","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.vaccine.2019.12.067","volume":"38","author":"E Tourtelot","year":"2020","unstructured":"Tourtelot E, Quataert S, Glantz JC, Perlis L, Muthukrishnan G, Mosmann T. Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels. Vaccine. 2020 Feb 11;38(7):1581\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.067.","journal-title":"Vaccine."},{"key":"6180_CR33","unstructured":"CDC. Shingles (Herpes Zoster). Available on: https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview.html. Last accessed on 03 december 2020."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06180-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T17:03:34Z","timestamp":1621962214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06180-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6180"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06180-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical committee of Osservatorio Epidemiologico Regionale approved this study. The study follows the principles of the World Medical Association Declaration of Helsinki, and does not involve any experiments on humans or human samples, nor research on identifiable human material and data. Written informed consent to participate in this study was obtained from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}